Skip to main content

HEALTH

  • Innovative BioDefense inks deal with Picketts Health to distribute Zylast antimicrobial product globally

    LAKE FOREST, Calif. — Innovative BioDefense, manufacturer of the Zylast line of broad-spectrum, persistent antimicrobial products, on Tuesday announced an exclusive relationship with Australian-based Picketts Health to provide a modification of their proprietary lotion and antiseptic sanitizer for use in Picketts Health’s patented Orbel hand sanitizer applicator.  

  • Pfizer acquires low-dose aspirin brand in Poland

    NEW YORK — Pfizer on Monday announced that a wholly-owned Polish subsidiary of Pfizer has acquired the rights to Polocard, a low-dose aspirin (acidum acetylsalicylicum), and the leading over-the-counter brand for heart attack prevention in Poland, from ZF Polpharma SA.

  • What goes around comes around

    I can hardly believe that I will once again have the distinct honor of facilitating a discussion with an impressive panel of industry leaders from both the retail and supplier side in this, my tenth appearance as moderator of Drug Store News’ Annual Diabetes Forum.

  • Shoppers Drug Mart launches new Life Brand products, debuts online 'Vitamin Finder'

    TORONTO — Canada’s Shoppers Drug Mart is expanding its Life Brand with the launch of Life Brand vitamins and supplements in store, and has introduced a new online tool, dubbed “Vitamin Finder,” to help Canadian’s find the products that best meet their health needs.

  • NAD refers Maxam Nutraceuticals to FTC

    NEW YORK — The National Advertising Division has referred advertising claims made by Maxam Nutraceuticals for its PCA dietary supplement to the Federal Trade Commission for further review, after the company declined to participate in a review of its claims.

    The Council for Responsible Nutrition challenged claims made by Maxam in television and Internet advertising, including:

  • Study: Antivirals like Tamiflu, Relenza reduce deaths among children critically ill with the flu

    ELK GROVE VILLAGE, Ill. — Treatment of influenza with such antiviral medicines as Tamiflu and Relenza may improve survival rates in children, according to a study published on Nov. 25 in Pediatrics. 

    Researchers from the California Department of Public Health analyzed data abstracted from medical records to characterize the outcomes of pediatric patients hospitalized with the flu between April 3, 2009 and September 30, 2012. 

  • Green Pharmaceuticals generates brand awareness with controversial ad campaign

    NEW YORK — Green Pharmaceuticals has drummed up some brand awareness for its SnoreStop stop-snoring solution with a controversial ad on Sunset Blvd. in Los Angeles, The Daily News reported last week. 

  • Researchers correlate increased heart risk to high-sodium medicines

    LONDON — Researchers at the University of Dundee and University College London on Wednesday found that taking the maximum daily dose of some medicines would exceed the recommended daily limits for sodium, without any additional dietary intake and potentially become an added risk factor for heart disease.

    They say the public "should be warned about the potential dangers of high sodium intake from prescribed medicines" and that sodium-containing formulations "should be prescribed with caution only if the perceived benefits outweigh the risks."

Related Topics

X
This ad will auto-close in 10 seconds